Angiotensin-converting enzyme inhibition abolishes medial smooth muscle PDGF-AB biosynthesis and attenuates cell proliferation in injured carotid arteries: Relationships to neointima formation

Circulation

Volumn 96, Issue 5, 1997, Pages 1631-1640

  Wong, James ^a   Rauhöft, Claudia ^a   Dilley, Rodney J ^a   Agrotis, Alex ^a   Jennings, Garry L ^a   Bobik, Alex ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

ACE inhibition; Angioplasty; Growth substances; Muscle; Smooth

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBROBLAST GROWTH FACTOR 2; PERINDOPRIL; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON CATHETER; BLOOD VESSEL INJURY; CAROTID ARTERY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; INTIMA; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RAT; RESTENOSIS; SMOOTH MUSCLE FIBER; TUNICA MEDIA;

EID: 0342506461     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.5.1631     Document Type: Article

References (37)

1. Lövqvist A, Emanuelsson H, Nilsson J, Lundqvist H, Carlsson J. Pathophysiological mechanisms for restenosis following coronary angioplasty: possible preventive alternatives. J Intern Med. 1993; 233:215-226.
2. Liu MW, Roubin GS, King SBI. Restenosis after coronary angioplasty: potential biological determinants and role of intimal hyperplasia. Circulation. 1989;79:1374-1387.
3. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
4. Bobik A, Campbell JH. Vascular derived growth factors: cell biology, pathophysiology and pharmacology. Pharmacol Rev. 1993; 45:1-42.
5. Powell JS, Clozel J-P, Müller RKM, Kuhn H, Hefti F, Hosang M, Baumgartner HR. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989;245:186-188.
6. O'Donohoe MK, Schwartz LB, Radic ZS, Mikat EM, McCann RL, Hagen PO. Chronic ACE inhibition reduces intimai hyperplasia in experimental vein grafts. Ann Surg. 1991;214:727-732.
7. Plissonnier K, Amichot G, Duriez ZS, Legagneux J, Levy BI, Michel JB. Effect of converting enzyme inhibition of allograft induced arterial wall injury and response. Hypertension. 1991; 18(suppl II):II-47-II-54.
8. Lam JYT, Lacoste L, Bourassa MG. Cilazapril and early atherosclerotic changes after balloon injury of porcine carotid arteries. Circulation. 1992;85:1542-1547.
9. Hanson SR, Powell JS, Dodson T, Lumsden A, Kelly AB, Anderson JS, Clowes AW, Harker L. Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension. 1991; 18(suppl II):II-70-II-76.
10. Mercator Study Group. Does the new angiotensin converting enzyme inhibitor prevent restenosis after percutaneous transluminal coronary angioplasty? Circulation. 1992;86:100-110.
11. Janiak P, Pillon A, Prost J-F, Wilaine J-P. Role of angiotensin subtype-2 receptor in neointima formation after vascular injury. Hypertension. 1992;20:737-745.
12. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured arterial wall. Circ Res. 1991;68:450-456.
13. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle growth response to angiotensin II. J Clin Invest. 1993;91:2268-2274.
14. Majack RA, Majesky MW, Goodman LV. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-β. J Cell Biol. 1990;111:239-247.
15. Lindner V, Reidy MA. Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries: an en face study. Circ Res. 1993;73:589-595.
16. Lombardi DM, Reidy AM, Schwartz SM. Methodological considerations important in the accurate quantitation of aortic smooth muscle cell replication in the normal rat. Am J Pathol. 1991;138: 441-446.
17. Reilly TM, Taylor DS, Herblin WF, Thoolen MJ, Chiu AT, Watson DW, Timmermans PB. Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo. Biochem Biophys Res Commun. 1989;164:736-743.
18. Östman A, Thyberg J, Westermark B, Heldin C-H. PDGF-AA and PDGF-BB biosynthesis: proprotein processing in the Golgi complex and lysosomal degradation of PDGF-BB retained intracellularly. J Cell Biol. 1992;118:509-519.
19. Chomczynski P, Sacchi N. Single step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:152-159.
20. 1→S progression. J Cell Sci. 1994;107: 227-239.
21. Xia Y, Feng L, Tang WW, Wilson CB. Cloning and expression of rat platelet derived growth factor A-chain. J Am Soc Nephrol. 1992;3:622-623.
22. Hemmerich P, von Mikecz A, Neumann F, Sozeri O, Wolff-Vorbeck, Zoebelein R, Krawinkel U. Structural and functional properties of ribosomal protein L7 from humans and rodents. Nucleic Acids Res. 1993;21:223-231.
23. Florkiewicz RZ, Baird A, Gonzalez A-M. Multiple forms of bFGF: differential nuclear and cell surface localization. Growth Factors. 1991;4:265-275.
24. 1 phase cell cycle specific in bovine aortic endothelial cells. EMBO J. 1990;9:1511-1517.
25. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol. 1990;111:2149-2158.
26. Ostman A, Andersson M, Betsholtz C, Westermark B, Heldin CH. Identification of a cell retention signal in the B-chain of platelet- derived growth factor and in the long splice version of the A-chain. Cell Regul. 1991;2:503-512.
27. Bowen-Pope DF, Hart CE, Seifert RA. Sera and conditioned media contain different isoforms of platelet derived growth factor (PDGF) which bind to different classes of PDGF receptor. J Biol Chem. 1989;264:2502-2508.
28. Sjolund M, Hedin U, Sejersen T, Heldin C-H, Thyherg J. Arterial smooth muscle cells express platelet derived growth factor (PDGF) A-chain mRNA, secrete a PDGF-like mitogen and hind exogenous PDGF in a phenotype and growth state-dependent manner. J Cell Biol. 1988;106:403-413.
29. Tanaka R, Sugehara K, Tatematsu A, Fogo A. Internephron heterogeneity of growth factors and sclerosis-modulation of platelet derived growth factor by angiotensin II. Kidney Int. 1995;47: 131-139.
30. Walker LN, Bowen-Pope DF, Ross R, Reidy MA. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci U S A. 1986;83:7311-7315.
31. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblastic growth factor. Proc Natl Acad Sci U S A. 1991;88:3739-3743.
32. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle cell migration and intimai thickening in a rat model of balloon angioplasty. J Clin Invest. 1992;89:507-511.
33. Koyama N, Morisaki N, Saito Y, Yoshida S. Regulatory effects of platelet derived growth factor-AA homodimers on migration of vascular smooth muscle cells. J Biol Chem. 1992;267:22806-22812.
34. 1 receptor antagonist. Am J Pathol. 1991;139:1291-1295.
35. Saltis J, Thomas AC, Agrotis A, Campbell JH, Campbell GR, Bobik A. Expression of growth factor receptors on arterial smooth muscle cells: dependency on cell phenotype and serum factors. Atherosclerosis. 1995;118:77-87.
36. Fingerle J, Miller RMK, Kuhn H, Pech M, Baumgartner HR. Mechanism of inhibition of neointimal formation by the angiotensin-converting enzyme inhibitor cilazapril: a study in balloon catheter-injured rat carotid arteries. Arterioscler Thromb Vasc Biol. 1995;15:1945-1950.
37. Morimoto S, Mizuno Y, Hiramitsu S. Restenosis after percutaneous transluminal angioplasty - a histopathological study using autopsied hearts. Jpn Circ J. 1990;54:43-56.